Estrella, M
Longitudinal association of depressive symptoms, binge eating, and quality of life with cardiovascular risk factors in young adults with youth-onset type 2 diabetes: the TODAY2 study
[DOI] [PubMed] [Google Scholar] Gorboulev V, Schrmann A, Vallon V, Kipp H, Jaschke A, Klessen D, Friedrich A, Scherneck S, Rieg T, Cunard R, 2012
Most are approved for patients with a body mass index above a specific cutoff, often 27 or 30, especially when other health problems, such as diabetes or heart disease, are present
Patients with certain GLP1R variants sometimes experience more pronounced side effects at standard doses, and genetic insights can guide your prescriber toward a more personalized dose titration schedule
People with type 2 diabetes have higher baseline rates of anxiety and depression compared to the general population, making it difficult to distinguish medication effects from underlying psychological comorbidity